Industry Focus
Healthcare: Carl Icahn Takes Aim At Bristol-Myers Squibb
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:21:04
- Mas informaciones
Informações:
Sinopsis
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.